Nephros (Nasdaq: NEPH) announced today that it has acquired almost all of the assets of Rockville, Md.–based GenArraytion.
The financial terms of the deal were not disclosed.
Nephros officials said the purchase will give their company access to a host of GenArraytion proprietary assays, multiplexing technology, and selection methods for detecting waterborne pathogens and other microorganisms through polymerase chain reaction (PCR) technology.
South Orange, N.J.–based Nephros provides filtration and pathogen detection solutions to the medical and commercial markets.
